May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
The Effectiveness of Moxifloxacin for Gram-Negative Bacterial Keratitis
Author Affiliations & Notes
  • B.A. Thibodeaux
    Microbiology, Immunology and Parasitology, LSU Health Sciences Center, New Orleans, LA, United States
  • J.J. Dajcs
    Microbiology, Immunology and Parasitology, LSU Health Sciences Center, New Orleans, LA, United States
  • A.R. Caballero
    Microbiology, Immunology and Parasitology, LSU Health Sciences Center, New Orleans, LA, United States
  • M.E. Marquart
    Microbiology, Immunology and Parasitology, LSU Health Sciences Center, New Orleans, LA, United States
  • D.O. Girgis
    Microbiology, Immunology and Parasitology, LSU Health Sciences Center, New Orleans, LA, United States
  • R.J. O'Callaghan
    Microbiology, Immunology and Parasitology, LSU Health Sciences Center, New Orleans, LA, United States
  • Footnotes
    Commercial Relationships  B.A. Thibodeaux, Alcon Laboratories Inc. F; J.J. Dajcs, None; A.R. Caballero, None; M.E. Marquart, None; D.O. Girgis, None; R.J. O'Callaghan, Alcon Laboratories Inc. F, R.
  • Footnotes
    Support  LSU Health Sciences Center Foundation and NEI grant EY 10974
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 1464. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      B.A. Thibodeaux, J.J. Dajcs, A.R. Caballero, M.E. Marquart, D.O. Girgis, R.J. O'Callaghan; The Effectiveness of Moxifloxacin for Gram-Negative Bacterial Keratitis . Invest. Ophthalmol. Vis. Sci. 2003;44(13):1464.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To determine the ability of topically applied moxifloxacin,a new fourth generation fluoroquinolone, to kill Pseudomonasor Serratia in the infected rabbit cornea.Methods: Log phaseP. aeruginosa strain 27853 or S. marcescens strain 93-1399-1were injected intrastromally (103 colony forming units [CFU]in 10 µl) into rabbit corneas (N=6). From 16 to 22 hourspostinfection (PI), a single topical drop of moxifloxacin (0.5%),levofloxacin (0.5%, Quixin®), ofloxacin (0.3%, Ocuflox®)or ciprofloxacin (0.3%, Ciloxan®) was applied every 30 minutesfor 13 doses. At 23 hours PI, corneas were harvested, homogenizedand cultured quantitatively.Results: For Pseudomonas keratitis,the untreated eyes contained over 7 log CFU of bacteria. Allantibiotic treated eyes contained significantly fewer log CFUper cornea than the untreated eyes, and ofloxacin therapy wasless effective than the other antibiotic therapies (P≤0.01). 

For Serratia keratitis, untreated eyes contained almost 7 logCFU. The log CFU per cornea for all treated eyes were significantlylower than the untreated eyes, and eyes treated with moxifloxacinhad significantly fewer bacteria than eyes treated with theother antibiotics tested (P≤0.001).   All four fluoroquinolones analyzed produced significant killingof Gram-negative bacteria in the rabbit cornea. Moxifloxacinwas the most effective of the four fluoroquinolones in eradicatingPseudomonas aeruginosa and Serratia marcescens in the rabbitkeratitis model.

Keywords: Pseudomonas • antibiotics/antifungals/antiparasitics • keratitis 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×